Loading...
Header Logo
Keywords
Last Name
Institution

Shellie Lucille Gorman Keast

TitleProf,Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
Phone405/271-8222
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pham TT, Skrepnek GH, Bond C, Alfieri T, Cothran TJ, Keast SL. Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016. Med Care. 2018 08; 56(8):727-735. PMID: 29995696.
      View in: PubMed
    2. Keast SL, Holderread B, Cothran T, Skrepnek GH. Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost. J Am Pharm Assoc (2003). 2018 Sep - Oct; 58(5):485-491. PMID: 30033127.
      View in: PubMed
    3. Pham TT, Keast SL, Farmer KC, Thompson DM, Rathbun RC, Nesser NJ, Holderread BP, Skrepnek GH. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676. PMID: 29952711.
      View in: PubMed
    4. Hartung DM, Kim H, Ahmed SM, Middleton L, Keast S, Deyo RA, Zhang K, McConnell KJ. Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes. Subst Abus. 2018; 39(2):239-246. PMID: 29016245.
      View in: PubMed
    5. Keast SL, Kim H, Deyo RA, Middleton L, McConnell KJ, Zhang K, Ahmed SM, Nesser N, Hartung DM. Effects of a prior authorization policy for extended-release/long-acting opioids on utilization and outcomes in a state Medicaid program. Addiction. 2018 Apr 20. PMID: 29679440.
      View in: PubMed
    6. Keast SL. Resource Use Evaluation of Tobramycin Formulations in a State Medicaid Program. J Pediatr Pharmacol Ther. 2018 Mar-Apr; 23(2):132-138. PMID: 29720915.
      View in: PubMed
    7. George DL, Smith MJ, Draugalis JR, Tolma EL, Keast SL, Wilson JB. Community pharmacists' beliefs regarding improvement of Star Ratings scores using the Theory of Planned Behavior. J Am Pharm Assoc (2003). 2018 Jan - Feb; 58(1):21-29. PMID: 29074146.
      View in: PubMed
    8. Keast SL, Pham T, Teel A, Nesser NJ. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program. J Manag Care Spec Pharm. 2017 Aug; 23(8):875-883. PMID: 28737989.
      View in: PubMed
    9. George DL, Smith MJ, Draugalis JR, Tolma EL, Keast SL, Wilson JB. The use of think-aloud protocols to identify a decision-making process of community pharmacists aimed at improving CMS Star Ratings scores. Res Social Adm Pharm. 2018 Mar; 14(3):262-268. PMID: 28356212.
      View in: PubMed
    10. Keast SL, Owora A, Nesser N, Farmer K. Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program. J Manag Care Spec Pharm. 2016 Apr; 22(4):347-56. PMID: 27023688.
      View in: PubMed
    11. Keast SL, Skrepnek G, Nesser N. State Medicaid Programs Bring Managed Care Tenets to Fee for Service. J Manag Care Spec Pharm. 2016 Feb; 22(2):145-8. PMID: 27015253.
      View in: PubMed
    12. Keast SL, Farmer K, Smith M, Nesser N, Harrison D. Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from research. Res Social Adm Pharm. 2016 Jan-Feb; 12(1):154-63. PMID: 25980583.
      View in: PubMed
    13. Keast SL, Nesser N, Farmer K. Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker's perspective. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):1-6. PMID: 25490606.
      View in: PubMed
    14. Keast SL, Thompson D, Farmer K, Smith M, Nesser N, Harrison D. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program. J Manag Care Spec Pharm. 2014 Jun; 20(6):612-21. PMID: 24856599.
      View in: PubMed
    15. Keast SL, Jacobs E, Harrison D, Farmer K, Thompson D. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population. Res Social Adm Pharm. 2010 Sep; 6(3):209-20. PMID: 20813334.
      View in: PubMed
    Keast's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description